United States · Who invested in Superluminal Medicines?
Superluminal Medicines's investors include Gaingels, Insight Partners, RA Capital Management, NVIDIA and Eli Lilly, and 1 more on record.
2026
?Venture$66MSeries BUnited States · Series B startup
Who invested in Superluminal Medicines
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 2 months ago
Funding summaryUpdated 26 Oct 2026
$66Mraised across 2 rounds since 2025, from 2 sources
- Latest round
- Series B, $66MSept 2026
- Investors
- 6
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture Aug 2025
- Biggest round
- $66M Series B · Sept 2026
- Between rounds
- 13 months from the last two
The rounds
- Sept 2026Series B$66M1 new4 returning
Source recordedSEC filing: $65M sold
- Aug 2025VentureAmount undisclosed5 new
Source recordedSEC filing: $5.0M sold, first sale Aug 2025
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Venture2025Series B2026
Gaingels
Insight Partners
RA Capital ManagementNVIDIA
Eli Lilly
Catalio Capital Management
GaingelsInsight PartnersRA Capital ManagementNVIDIAEli LillyCatalio Capital ManagementEveryone who backed them
NVIDIACompany2rounds
Missing a round, or an investor who was in one? Tell us.
Quick answers about Superluminal Medicines
How much has Superluminal Medicines raised?
Superluminal Medicines has raised $66M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
When did Superluminal Medicines last raise?
Superluminal Medicines's most recent round was a Series B of $66M in Sept 2026.
What was Superluminal Medicines's biggest round?
Its most recent round, $66M in Sept 2026, is also its largest on record.
Who backed Superluminal Medicines first?
Superluminal Medicines's first round on record, in Aug 2025, was backed by Gaingels, Insight Partners and RA Capital Management and 2 others.
What stage is Superluminal Medicines at?
Superluminal Medicines's latest named round is a Series B, in Sept 2026.
Where is Superluminal Medicines based?
Superluminal Medicines is based in the United States.
Companies like Superluminal Medicines
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.